Northshore Clinical Associates

Erie, Pennsylvania 16507

0 studies enrolling now · 3 studies all time

What they study most

Brain Infarction, Cerebral Ischemia, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Stroke

Studies at this site

• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy — Completed
• Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early